BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21515295)

  • 1. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.
    Williams DL; Hyvarinen N; Lilly N; Kay K; Dossat A; Parise E; Torregrossa AM
    Physiol Behav; 2011 Jul; 103(5):557-64. PubMed ID: 21515295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.
    Mul JD; Begg DP; Barrera JG; Li B; Matter EK; D'Alessio DA; Woods SC; Seeley RJ; Sandoval DA
    Am J Physiol Regul Integr Comp Physiol; 2013 Jul; 305(1):R68-77. PubMed ID: 23616105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
    Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
    Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
    Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.
    Steinert RE; Schirra J; Meyer-Gerspach AC; Kienle P; Fischer H; Schulte F; Goeke B; Beglinger C
    Am J Clin Nutr; 2014 Aug; 100(2):514-23. PubMed ID: 24965303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist exendin-4.
    Duca FA; Sakar Y; Covasa M
    Diabetes; 2013 Jul; 62(7):2410-5. PubMed ID: 23423571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.
    Hayes MR; Bradley L; Grill HJ
    Endocrinology; 2009 Jun; 150(6):2654-9. PubMed ID: 19264875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of lateral septum glucagon-like peptide 1 receptors in food intake.
    Terrill SJ; Jackson CM; Greene HE; Lilly N; Maske CB; Vallejo S; Williams DL
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R124-32. PubMed ID: 27194565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
    Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
    Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew).
    Chan SW; Lin G; Yew DT; Yeung CK; Rudd JA
    Neuropharmacology; 2013 Jul; 70():141-7. PubMed ID: 23357334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats.
    Peters CT; Choi YH; Brubaker PL; Anderson GH
    J Nutr; 2001 Aug; 131(8):2164-70. PubMed ID: 11481412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.
    Williams DL; Baskin DG; Schwartz MW
    Endocrinology; 2009 Apr; 150(4):1680-7. PubMed ID: 19074583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake.
    Dossat AM; Lilly N; Kay K; Williams DL
    J Neurosci; 2011 Oct; 31(41):14453-7. PubMed ID: 21994361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
    Bojanowska E; Radziszewska E
    J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anorexic effects of intra-VTA leptin are similar in low-fat and high-fat-fed rats but attenuated in a subgroup of high-fat-fed obese rats.
    Bruijnzeel AW; Qi X; Corrie LW
    Pharmacol Biochem Behav; 2013 Jan; 103(3):573-81. PubMed ID: 23107643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
    Radziszewska E; Bojanowska E
    Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
    Dickson SL; Shirazi RH; Hansson C; Bergquist F; Nissbrandt H; Skibicka KP
    J Neurosci; 2012 Apr; 32(14):4812-20. PubMed ID: 22492036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleus accumbens GLP-1 receptors influence meal size and palatability.
    Dossat AM; Diaz R; Gallo L; Panagos A; Kay K; Williams DL
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1314-20. PubMed ID: 23612998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors.
    Mietlicki-Baase EG; Ortinski PI; Rupprecht LE; Olivos DR; Alhadeff AL; Pierce RC; Hayes MR
    Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1367-74. PubMed ID: 24105414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.